IMMUNIC CEO Erik Lundgren files Form 3

IMMUNIC, INC. filed an initial Form 3 ownership report for Chief Executive Officer Erik Lundgren.

Rhea-AI Filing Summary

IMMUNIC, INC. filed an initial Form 3 ownership report for Chief Executive Officer Erik Lundgren. The filing lists him as an officer of the company but does not report any specific share or option holdings and shows no purchases, sales, or other insider transactions. This is a baseline disclosure establishing his status as a reporting person for future ownership and trading reports.

Key Terms

Form 3, Chief Executive Officer, reporting person, netBuySellDirection

4 terms

Form 3 regulatory

"IMMUNIC, INC. filed an initial Form 3 ownership report for Chief Executive Officer Erik Lundgren."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Chief Executive Officer financial

"The Form 3 describes Erik Lundgren as an officer of IMMUNIC, INC. with the title of Chief Executive Officer."

A chief executive officer (CEO) is the top leader of a company, responsible for making major decisions, setting goals, and guiding the organization’s overall direction. Think of the CEO as the captain of a ship, steering it toward success. Investors pay close attention to the CEO because their leadership and strategy can significantly influence the company's performance and future growth.

reporting person regulatory

"This is a baseline disclosure establishing his status as a reporting person for future ownership and trading reports."

netBuySellDirection technical

"The transaction summary indicates netBuySellShares of zero and a netBuySellDirection of neutral."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the IMMUNIC, INC. (IMUX) Form 3 filing for Erik Lundgren show?

The Form 3 filing identifies Erik Lundgren as Chief Executive Officer of IMMUNIC, INC. It establishes him as a reporting insider but shows no reported share, option, or other security transactions or holdings in this filing.

Did IMMUNIC, INC. CEO Erik Lundgren buy or sell IMUX shares in this Form 3?

No. The transaction summary in the Form 3 for Erik Lundgren shows zero buys, zero sells, and no other types of insider transactions. It functions solely as an initial ownership report without trade activity.

Does the IMUX Form 3 disclose any derivative positions for Erik Lundgren?

No derivative positions are listed for Erik Lundgren in the Form 3. The derivative summary section is empty, and the transaction summary shows no derivative exercises, conversions, or other derivative-related activities reported.

What insider role does Erik Lundgren hold at IMMUNIC, INC. in this filing?

The Form 3 describes Erik Lundgren as an officer of IMMUNIC, INC. with the title of Chief Executive Officer. He is not reported as a director or ten percent owner in this specific filing’s role disclosures.

Does this IMMUNIC, INC. Form 3 indicate any net buying or selling by Erik Lundgren?

No. The transaction summary indicates netBuySellShares of zero and a netBuySellDirection of neutral. This confirms there is no net buying or selling activity reported for Erik Lundgren in this Form 3.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 05:56 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lundgren Erik

(Last) (First) (Middle)

1200 AVENUE OF THE AMERICAS, SUITE 200

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2026

3. Issuer Name and Ticker or Trading Symbol
IMMUNIC, INC. [ IMUX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

No securities are beneficially owned.

	/s/ Grant Levine, attorney-in-fact	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)